Stoke Therapeutics, Inc. (FRA:0GT)

Stoke Therapeutics Statistics

Total Valuation

FRA:0GT has a market cap or net worth of EUR 1.52 billion. The enterprise value is 1.24 billion.

Market Cap	1.52B
Enterprise Value	1.24B

Important Dates

The next estimated earnings date is Friday, March 6, 2026.

Earnings Date	Mar 6, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	57.12M
Shares Outstanding	n/a
Shares Change (YoY)	+16.83%
Shares Change (QoQ)	+0.44%
Owned by Insiders (%)	4.10%
Owned by Institutions (%)	94.65%
Float	40.84M

Valuation Ratios

The trailing PE ratio is 44.04.

PE Ratio	44.04
Forward PE	n/a
PS Ratio	8.69
PB Ratio	5.80
P/TBV Ratio	5.80
P/FCF Ratio	34.11
P/OCF Ratio	33.80
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 46.23, with an EV/FCF ratio of 27.86.

EV / Earnings	35.96
EV / Sales	7.01
EV / EBITDA	46.23
EV / EBIT	53.01
EV / FCF	27.86

Financial Position

The company has a current ratio of 6.53, with a Debt / Equity ratio of 0.02.

Current Ratio	6.53
Quick Ratio	6.21
Debt / Equity	0.02
Debt / EBITDA	0.15
Debt / FCF	0.09
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 15.02% and return on invested capital (ROIC) is 6.18%.

Return on Equity (ROE)	15.02%
Return on Assets (ROA)	5.20%
Return on Invested Capital (ROIC)	6.18%
Return on Capital Employed (ROCE)	8.54%
Revenue Per Employee	1.37M
Profits Per Employee	270,119
Employee Count	128
Asset Turnover	0.63
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +141.44% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+141.44%
50-Day Moving Average	23.71
200-Day Moving Average	13.65
Relative Strength Index (RSI)	62.25
Average Volume (20 Days)	115

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	9.34

Income Statement

In the last 12 months, FRA:0GT had revenue of EUR 175.26 million and earned 34.58 million in profits. Earnings per share was 0.58.

Revenue	175.26M
Gross Profit	175.26M
Operating Income	23.18M
Pretax Income	34.58M
Net Income	34.58M
EBITDA	24.79M
EBIT	23.18M
Earnings Per Share (EPS)	0.58

Balance Sheet

The company has 211.63 million in cash and 4.08 million in debt, giving a net cash position of 276.01 million.

Cash & Cash Equivalents	211.63M
Total Debt	4.08M
Net Cash	276.01M
Net Cash Per Share	n/a
Equity (Book Value)	262.60M
Book Value Per Share	4.76
Working Capital	196.63M

Cash Flow

In the last 12 months, operating cash flow was 45.04 million and capital expenditures -409,104, giving a free cash flow of 44.63 million.

Operating Cash Flow	45.04M
Capital Expenditures	-409,104
Free Cash Flow	44.63M
FCF Per Share	n/a

Margins

Gross margin is 100.00%, with operating and profit margins of 13.23% and 19.73%.

Gross Margin	100.00%
Operating Margin	13.23%
Pretax Margin	19.73%
Profit Margin	19.73%
EBITDA Margin	14.15%
EBIT Margin	13.23%
FCF Margin	25.47%

Dividends & Yields

FRA:0GT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.83%
Shareholder Yield	-16.83%
Earnings Yield	2.27%
FCF Yield	2.93%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:0GT has an Altman Z-Score of 7.4 and a Piotroski F-Score of 6.

Altman Z-Score	7.4
Piotroski F-Score	6